-
2
-
-
77949878932
-
Drug delivery by red blood cells: Vascular carriers designed by mother nature
-
Muzykantov VR. Drug delivery by red blood cells: Vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010;7:403-27
-
(2010)
Expert Opin. Drug Deliv
, vol.7
, pp. 403-427
-
-
Muzykantov, V.R.1
-
3
-
-
0033045479
-
Survival of human carrier erythrocytes in vivo
-
Bax BE, Bain MD, Talbot PJ, et al. Survival of human carrier erythrocytes in vivo. Clin Sci (Lond) 1999;96:171-8 (Pubitemid 29094936)
-
(1999)
Clinical Science
, vol.96
, Issue.2
, pp. 171-178
-
-
Bax, B.E.1
Bain, M.D.2
Talbot, P.J.3
Parker-Williams, E.J.4
Chalmers, R.A.5
-
4
-
-
79952607367
-
L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: Results of the graspall 2005- 01 randomized trial
-
Domenech C, Thomas X, Chabaud S, et al. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: Results of the GRASPALL 2005-01 randomized trial. Br J Haematol 2011;153:58-65
-
(2011)
Br. J. Haematol.
, Issue.153
, pp. 58-65
-
-
Domenech, C.1
Thomas, X.2
Chabaud, S.3
-
5
-
-
52449090145
-
Carrier erythrocyte entrapped thymidine phosphorylasetherapy for mngie
-
Moran NF, Bain MD, Muqit MMK, Bax BE. Carrier erythrocyte entrapped thymidine phosphorylasetherapy for MNGIE. Neurology 2008;71:686-8
-
(2008)
Neurology
, vol.71
, pp. 686-688
-
-
Moran, N.F.1
Bain, M.D.2
Muqit, M.M.K.3
Bax, B.E.4
-
6
-
-
34548593279
-
A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency
-
DOI 10.1111/j.1600-0609.2007.00927.x
-
Bax BE, Bain MD, Fairbanks LD, et al. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. Eur J Haematol 2007;79:338-48 (Pubitemid 47390137)
-
(2007)
European Journal of Haematology
, vol.79
, Issue.4
, pp. 338-348
-
-
Bax, B.E.1
Bain, M.D.2
Fairbanks, L.D.3
Webster, A.D.B.4
Ind, P.W.5
Hershfield, M.S.6
Chalmers, R.A.7
-
7
-
-
57749083391
-
Encapsulation of glutamine synthetase in mouse erythrocytes: A new procedure for ammonia detoxification
-
Kosenko EA, Venediktova NI, Kudryavtsev AA, et al. Encapsulation of glutamine synthetase in mouse erythrocytes: A new procedure for ammonia detoxification. Biochem Cell Biol 2008;86:469-76
-
(2008)
Biochem. Cell Biol.
, vol.86
, pp. 469-476
-
-
Kosenko, E.A.1
Venediktova, N.I.2
Kudryavtsev, A.A.3
-
8
-
-
77958093410
-
A new drug form of blood coagulation factor IX: Red blood cell-entrapped factor IX
-
Sinauridze EI, Vuimo TA, Kulikova EV, et al. A new drug form of blood coagulation factor IX: Red blood cell-entrapped factor IX. Med Sci Monit 2010;16:I19-26
-
(2010)
Med. Sci. Monit.
, vol.16
-
-
Sinauridze, E.I.1
Vuimo, T.A.2
Kulikova, E.V.3
-
10
-
-
0242573461
-
Anemia in the Treatment of Hepatitis C Virus Infection
-
DOI 10.1086/376911
-
Sulkowski MS. Anemia in the treatment of hepatitis C virus infection. Clin Infect Dis 2003;37(Suppl 4):S315-22 (Pubitemid 37431008)
-
(2003)
Clinical Infectious Diseases
, vol.37
, Issue.SUPPL. 4
-
-
Sulkowski, M.S.1
-
11
-
-
1942534729
-
Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia
-
Skorokhod OA, Garmaeva TT, Vitvitsky VM, et al. Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia. Med Sci Monit 2004;10:I55-64
-
(2004)
Med. Sci. Monit.
, vol.10
-
-
Skorokhod, O.A.1
Garmaeva, T.T.2
Vitvitsky, V.M.3
-
12
-
-
34547682311
-
Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes
-
Skorokhod O, Kulikova EV, Galkina NM, et al. Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes. Haematologica 2007;92:570-1
-
(2007)
Haematologica
, vol.92
, pp. 570-57
-
-
Skorokhod, O.1
Kulikova, E.V.2
Galkina, N.M.3
-
13
-
-
38349132566
-
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
-
Briones E, Colino CI, Lanao JM. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 2008;125:210-27
-
(2008)
J. Control Release
, vol.125
, pp. 210-227
-
-
Briones, E.1
Colino, C.2
Lanao, J.M.3
-
14
-
-
38449087460
-
Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes
-
Gutierrez MC, Zarzuelo CA, Gonzalez LF, et al. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes. J Antimicrob Chemother 2008;61:375-81
-
(2008)
J. Antimicrob. Chemother
, vol.61
, pp. 375-381
-
-
Gutierrez, M.C.1
Zarzuelo, C.A.2
Gonzalez, L.F.3
-
15
-
-
70349835152
-
Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
-
Briones E, Colino CI, Millan CG, Lanao JM. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes. Eur J Pharm Sci 2009;38:320-4
-
(2009)
Eur. J. Pharm. Sci.
, vol.38
, pp. 320-324
-
-
Briones, E.1
Colino, C.I.2
Millan, C.G.3
Lanao, J.M.4
-
16
-
-
77949657392
-
In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy
-
Banz A, Cremel M, Rembert A, Godfrin Y. In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy. Vaccine 2010;28:2965-72
-
(2010)
Vaccine
, vol.28
, pp. 2965-2972
-
-
Banz, A.1
Cremel, M.2
Rembert, A.3
Godfrin, Y.4
-
17
-
-
62849129028
-
Current issues in blood transfusion for sickle cell disease
-
Wahl S, Quirolo KC. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr 2009;21:15-21
-
(2009)
Curr. Opin. Pediatr.
, vol.21
, pp. 15-21
-
-
Wahl, S.1
Quirolo, K.C.2
-
18
-
-
78649487662
-
Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling
-
Bourgeaux V, Hequet O, Campion Y, et al. Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling. Transfusion 2010;50:2176-84
-
(2010)
Transfusion
, vol.50
, pp. 2176-2184
-
-
Bourgeaux, V.1
Hequet, O.2
Campion, Y.3
-
19
-
-
77954687045
-
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation
-
Zaitsev S, Spitzer D, Murciano JC, et al. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood 2010;115:5241-8
-
(2010)
Blood
, vol.115
, pp. 5241-5248
-
-
Zaitsev, S.1
Spitzer, D.2
Murciano, J.C.3
|